Table 2.
Effect of paricalcitol on mineral homeostasis.
| Treatment | Five weeks | Seven weeks | ||||||
|---|---|---|---|---|---|---|---|---|
| Group | I | II | III | IV | I | II | III | IV |
|
| ||||||||
| 1.25 vitamin D3 (pmol/L) | 436.0 | 342.0 | 564.0 | 310.5 | 255.5 | 33.5a | 384 | 42b |
| IQR | [352.8–519.3] | [256.0–427.0] | [427.5–673.5] | [288.0–365.3] | [225–279] | [30.8–36] | [330.8–456.8] | [39–45] |
| 25 vitamin D3 | No data | No data | No data | No data | 63 | 39a | 75.5 | 52b |
| IQR | [59.5–70.8] | [37.8–40.5] | [69.3–79.8] | [51–54] | ||||
| Phosphate (mmol/L) | 3.4 | 4.6a,b | 3.3a | 3.2 | 3.0 | 3.4 | 3.6 | 4.1 |
| IQR | [2.7–4.1] | [4.0–4.7] | [3.2–3.4] | [2.8–3.6] | [3.0–3.2] | [3.1–3.5] | [3.6–4.5] | [3.6–5.4] |
| Calcium (mmol/L) | 3.6 | 3.6 | 3.5 | 3.4 | 3.2 | 3.1 | 3.4 | 3.4 |
| IQR | [3.6–3.8] | [3.4–3.8] | [3.2–3.5] | [3.3–3.5] | [3.1–3.3] | [3.2–3.0] | [3.3–3.6] | [3.4–3.2] |
All data presented as median and interquartiles.
a p < 0.05 compared to group I; b p < 0.05 compared to group III.